A recent study suggests that patients who discontinue blockbuster GLP-1 drugs like semaglutide or tirzepatide may regain reduced body mass much more quickly than those who end conventional lifestyle regimens.
Findings released in a leading health publication shows that while overweight people frequently drop substantial amounts of their body weight while using the jabs, the weight comes back at an estimated rate of 0.8 kg per month once they quit.
"People buying these drugs need to be cognizant of the danger of rapid weight regain when the therapy ends," cautioned researcher Dr. Susan Jebb.
This pace of regain implies a return to pre-treatment mass within about 18 months.
Analyzing Therapies
The analysis, which examined 37 of studies involving thousands of participants, contrasted the outcomes of GLP-1 agonists with older methods.
Researchers emphasize that individuals who shed pounds through diet and exercise typically have a less rapid creep back—approximately 100 grams monthly—post-intervention.
Explaining the Quick Regain
Doctors suggest the mechanism of the jabs is key to understanding the accelerated regain.
GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Sustained high doses of GLP-1 concentrations several times higher than the body's typical production could lead to the body to produce less of its own natural GLP-1, and could diminish responsiveness to its actions," noted Dr. Adam Collins, a dietetics researcher.
"Stopping of this hormone supplement means appetite is no longer kept in check, making binge eating far more likely."
A Chronic Issue?
The NHS advise the injections for people with weight-linked medical conditions, alongside prescribed diet and exercise modifications.
Professionals say that, considering the significant potential of weight regain, the therapy should be considered life-long.
This perspective is supported by drug manufacturers, who state that the results "highlight the long-term character of obesity," akin to managing diseases like diabetes.
User Testimonies
Users who have stopped the jabs report a intense return of cravings.
"It was like something that goes on and you're instantly starving," said one woman.
This challenge is compounded if individuals have not developed permanent dietary or behavioural changes during treatment.
Growing Interest
Recent estimates show that a significant number of people in the UK have tried weight-loss jabs in the past year, with desire continuing to grow.
- Adoption is higher among females compared to males.
- The 40s and 50s age group shows the greatest level of interest.
- Many access the medications through private healthcare rather than the NHS.
In conclusion, experts stress that while the jabs are potent agents for shedding pounds, they are not a standalone solution and lasting health benefits hinges on integrated lifestyle management.
